Ueno, S.; Kim, M.W.; Lee, G.; Park, Y.I.; Niidome, T.; Lee, R.
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer. Pharmaceutics 2020, 12, 585.
https://doi.org/10.3390/pharmaceutics12060585
AMA Style
Ueno S, Kim MW, Lee G, Park YI, Niidome T, Lee R.
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer. Pharmaceutics. 2020; 12(6):585.
https://doi.org/10.3390/pharmaceutics12060585
Chicago/Turabian Style
Ueno, Sho, Min Woo Kim, Gibok Lee, Yong Il Park, Takuro Niidome, and Ruda Lee.
2020. "Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer" Pharmaceutics 12, no. 6: 585.
https://doi.org/10.3390/pharmaceutics12060585
APA Style
Ueno, S., Kim, M. W., Lee, G., Park, Y. I., Niidome, T., & Lee, R.
(2020). Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer. Pharmaceutics, 12(6), 585.
https://doi.org/10.3390/pharmaceutics12060585